FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148879080> ?p ?o ?g. }

• W2148879080 endingPage "1965" @default.
• W2148879080 startingPage "1953" @default.
• W2148879080 abstract "Objective. To assess the effects of epigallocatechin-3-gallate (EGCG) on cytokine-induced Cyr61 synthesis in human osteoblastic cells and the associated signalling pathways. The therapeutic effect of EGCG on CIA in rats was also studied. Methods. The expression of Cyr61 and NF-κB pathway molecules was examined by western blotting. CCL2 expression was assessed by northern blotting and ELISA. Interaction between NF-κB and Cyr61 promoter was evaluated by electrophoretic mobility shift assay. In rat CIA, osteoblastic expression of Cyr61 was examined by immunohistochemistry and disease progression was assessed by clinical, radiographic and histological examinations. Results. EGCG inhibited Cyr61 expression stimulated by cytokines in primary human osteoblasts and human osteoblastic cell line U2OS. In U2OS, oncostatin M (OSM) induced IκB-α degradation through the mTOR/rictor/Akt pathway, and EGCG attenuated the action. Electrophoretic mobility shift assay revealed that the OSM-enhanced NF-κB/DNA binding was reduced by EGCG, possibly through abrogating nucleus localization of p65 and p50. Cyr61 enhanced OSM-induced expression of CCL2. Moreover, EGCG diminished OSM-stimulated CCL2 expression at least partially via suppressing Cyr61 induction. Co-distribution of CD68+ macrophages and Cyr61+ osteoblasts in osteolytic areas was obvious in the CIA model. Clinical, radiographic and immunohistochemical analyses revealed that administration of EGCG markedly diminished the severity of CIA, macrophage infiltration, and the number of Cyr61-synthesizing osteoblasts. Conclusion. By modulating the mTOR/rictor/Akt/NF-κB pathway, EGCG attenuated Cyr61 production in osteoblastic cells and in turn diminished macrophage chemotaxis. Our data support the therapeutic potential of EGCG on arthritis." @default.
• W2148879080 created "2016-06-24" @default.
• W2148879080 creator A5009045771 @default.
• W2148879080 creator A5021986036 @default.
• W2148879080 creator A5031263543 @default.
• W2148879080 creator A5033189282 @default.
• W2148879080 creator A5035761607 @default.
• W2148879080 creator A5036665472 @default.
• W2148879080 creator A5040953451 @default.
• W2148879080 creator A5043969943 @default.
• W2148879080 creator A5051348233 @default.
• W2148879080 creator A5082827000 @default.
• W2148879080 date "2012-07-28" @default.
• W2148879080 modified "2023-10-18" @default.
• W2148879080 title "Epigallocatechin-3-gallate diminishes cytokine-stimulated Cyr61 expression in human osteoblastic cells: a therapeutic potential for arthritis" @default.
• W2148879080 cites W1617532721 @default.
• W2148879080 cites W1964416890 @default.
• W2148879080 cites W1970315050 @default.
• W2148879080 cites W1976242183 @default.
• W2148879080 cites W1983698019 @default.
• W2148879080 cites W1983767980 @default.
• W2148879080 cites W1993325779 @default.
• W2148879080 cites W1993500513 @default.
• W2148879080 cites W1994398697 @default.
• W2148879080 cites W2003402857 @default.
• W2148879080 cites W2005376689 @default.
• W2148879080 cites W2014096417 @default.
• W2148879080 cites W2022207376 @default.
• W2148879080 cites W2028433832 @default.
• W2148879080 cites W2036824008 @default.
• W2148879080 cites W2040966337 @default.
• W2148879080 cites W2048563910 @default.
• W2148879080 cites W2069539988 @default.
• W2148879080 cites W2074206746 @default.
• W2148879080 cites W2075091190 @default.
• W2148879080 cites W2080246461 @default.
• W2148879080 cites W2085039873 @default.
• W2148879080 cites W2087920840 @default.
• W2148879080 cites W2106171259 @default.
• W2148879080 cites W2107396673 @default.
• W2148879080 cites W2118017964 @default.
• W2148879080 cites W2129585918 @default.
• W2148879080 cites W2153678300 @default.
• W2148879080 cites W4238567307 @default.
• W2148879080 doi "https://doi.org/10.1093/rheumatology/kes174" @default.
• W2148879080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22843790" @default.
• W2148879080 hasPublicationYear "2012" @default.
• W2148879080 type Work @default.
• W2148879080 sameAs 2148879080 @default.
• W2148879080 citedByCount "9" @default.
• W2148879080 countsByYear W21488790802013 @default.
• W2148879080 countsByYear W21488790802014 @default.
• W2148879080 countsByYear W21488790802017 @default.
• W2148879080 countsByYear W21488790802020 @default.
• W2148879080 countsByYear W21488790802021 @default.
• W2148879080 countsByYear W21488790802022 @default.
• W2148879080 crossrefType "journal-article" @default.
• W2148879080 hasAuthorship W2148879080A5009045771 @default.
• W2148879080 hasAuthorship W2148879080A5021986036 @default.
• W2148879080 hasAuthorship W2148879080A5031263543 @default.
• W2148879080 hasAuthorship W2148879080A5033189282 @default.
• W2148879080 hasAuthorship W2148879080A5035761607 @default.
• W2148879080 hasAuthorship W2148879080A5036665472 @default.
• W2148879080 hasAuthorship W2148879080A5040953451 @default.
• W2148879080 hasAuthorship W2148879080A5043969943 @default.
• W2148879080 hasAuthorship W2148879080A5051348233 @default.
• W2148879080 hasAuthorship W2148879080A5082827000 @default.
• W2148879080 hasBestOaLocation W21488790801 @default.
• W2148879080 hasConcept C101666144 @default.
• W2148879080 hasConcept C126322002 @default.
• W2148879080 hasConcept C13373296 @default.
• W2148879080 hasConcept C134018914 @default.
• W2148879080 hasConcept C170493617 @default.
• W2148879080 hasConcept C2775960820 @default.
• W2148879080 hasConcept C2776914184 @default.
• W2148879080 hasConcept C2777730290 @default.
• W2148879080 hasConcept C2778690821 @default.
• W2148879080 hasConcept C2778753947 @default.
• W2148879080 hasConcept C2780631158 @default.
• W2148879080 hasConcept C2781184567 @default.
• W2148879080 hasConcept C502942594 @default.
• W2148879080 hasConcept C62478195 @default.
• W2148879080 hasConcept C71924100 @default.
• W2148879080 hasConcept C75217442 @default.
• W2148879080 hasConcept C86554907 @default.
• W2148879080 hasConcept C86803240 @default.
• W2148879080 hasConcept C95444343 @default.
• W2148879080 hasConceptScore W2148879080C101666144 @default.
• W2148879080 hasConceptScore W2148879080C126322002 @default.
• W2148879080 hasConceptScore W2148879080C13373296 @default.
• W2148879080 hasConceptScore W2148879080C134018914 @default.
• W2148879080 hasConceptScore W2148879080C170493617 @default.
• W2148879080 hasConceptScore W2148879080C2775960820 @default.
• W2148879080 hasConceptScore W2148879080C2776914184 @default.
• W2148879080 hasConceptScore W2148879080C2777730290 @default.
• W2148879080 hasConceptScore W2148879080C2778690821 @default.
• W2148879080 hasConceptScore W2148879080C2778753947 @default.
• W2148879080 hasConceptScore W2148879080C2780631158 @default.

• next